Literature DB >> 30238334

Preoperative Portal Vein Embolization Alone with Biliary Drainage Compared to a Combination of Simultaneous Portal Vein, Right Hepatic Vein Embolization and Biliary Drainage in Klatskin Tumor.

Arnaud Hocquelet1, Charalampos Sotiriadis2, Rafael Duran2, Boris Guiu3, Takamune Yamaguchi4, Nermin Halkic4, Emmanuel Melloul4, Nicolas Demartines4, Alban Denys2.   

Abstract

PURPOSE: To compare estimated future remnant liver (FRL) growth following portal vein embolization or liver venous deprivation (LVD) (combined PVE and right hepatic vein embolization), before surgery for a Klatskin tumor in patients who receive intraoperative biliary drainage or before venous interventional radiology. MATERIAL AND
METHOD: Six patients underwent LVD and six underwent PVE alone before hepatectomy for a Klatskin tumor. Before embolization, the FRL ratio, prothrombin time and bilirubin levels were similar in both groups. The FRL was determined before and 3 weeks after embolization by enhanced CT. PVE was performed with n-butyl-2-cyanoacrylate, and the right hepatic vein was embolized with vascular plugs during the same procedure. Biliary drainage was performed percutaneously or by endoscopy. Post-hepatectomy liver function and duration of hospital stay were assessed.
RESULTS: There were no adverse events. The median FRL ratio was significantly higher following LVD than after PVE 58% (54-71) and 37% (30-44), respectively, p = 0.017. The FRL volume after embolization was 1.6 times higher after LVD than PVE (p = 0.016). Four and five patients were operated in the LVD and PVE groups, respectively. There was a trend toward a shorter median postoperative hospital stay and 90-day mortality in the LVD versus PVE group: 14 versus 44 days, (p = 0.114) and 0 versus two deaths (p = 0.429), respectively.
CONCLUSIONS: LVD associated with biliary drainage is safe and results in a better FRL ratio than biliary drainage associated with PVE alone.

Entities:  

Keywords:  Biliary drainage; Future remnant liver; Hepatic vein embolization; Klatskin tumor; Portal vein embolization; Safety

Mesh:

Year:  2018        PMID: 30238334     DOI: 10.1007/s00270-018-2075-0

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  9 in total

Review 1.  Imaging-guided interventions modulating portal venous flow: Evidence and controversies.

Authors:  Roberto Cannella; Lambros Tselikas; Fréderic Douane; François Cauchy; Pierre-Emmanuel Rautou; Rafael Duran; Maxime Ronot
Journal:  JHEP Rep       Date:  2022-04-04

2.  Perioperative impact of liver venous deprivation compared with portal venous embolization in patients undergoing right hepatectomy: preliminary results from the pioneer center.

Authors:  Fabrizio Panaro; Fabio Giannone; Benjamin Riviere; Olivia Sgarbura; Caterina Cusumano; Emmanuel Deshayes; Francis Navarro; Boris Guiu; Francois Quenet
Journal:  Hepatobiliary Surg Nutr       Date:  2019-08       Impact factor: 7.293

3.  Liver Venous Deprivation (LVD) Versus Portal Vein Embolization (PVE) Alone Prior to Extended Hepatectomy: A Matched Pair Analysis.

Authors:  Georg Böning; Uli Fehrenbach; Timo Alexander Auer; Konrad Neumann; Martin Jonczyk; Johann Pratschke; Wenzel Schöning; Moritz Schmelzle; Bernhard Gebauer
Journal:  Cardiovasc Intervent Radiol       Date:  2022-03-21       Impact factor: 2.797

4.  Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy for colo-rectal liver metastases.

Authors:  Emmanuel Deshayes; Lauranne Piron; Antoine Bouvier; Bruno Lapuyade; Emilie Lermite; Laurent Vervueren; Christophe Laurent; Jean-Baptiste Pinaquy; Patrick Chevallier; Anthony Dohan; Agnès Rode; Christian Sengel; Chloé Guillot; François Quenet; Boris Guiu
Journal:  BMC Cancer       Date:  2020-06-19       Impact factor: 4.430

5.  New evidence for liver venous deprivation: safety and feasibility for extended liver resections.

Authors:  Jiang Zhang; Christian J Steib
Journal:  Ann Transl Med       Date:  2020-10

Review 6.  Simultaneous portal and hepatic vein embolization before major liver resection.

Authors:  Jan Heil; Erik Schadde
Journal:  Langenbecks Arch Surg       Date:  2020-08-24       Impact factor: 3.445

7.  Dragon 1 Protocol Manuscript: Training, Accreditation, Implementation and Safety Evaluation of Portal and Hepatic Vein Embolization (PVE/HVE) to Accelerate Future Liver Remnant (FLR) Hypertrophy.

Authors:  E Schadde; R M van Dam; R Korenblik; B Olij; L A Aldrighetti; M Abu Hilal; M Ahle; B Arslan; L J van Baardewijk; I Baclija; C Bent; C L Bertrand; B Björnsson; M T de Boer; S W de Boer; R P H Bokkers; I H M Borel Rinkes; S Breitenstein; R C G Bruijnen; P Bruners; M W Büchler; J C Camacho; A Cappelli; U Carling; B K Y Chan; D H Chang; J Choi; J Codina Font; M Crawford; D Croagh; E Cugat; R Davis; D W De Boo; F De Cobelli; J F De Wispelaere; O M van Delden; M Delle; O Detry; R Díaz-Nieto; A Dili; J I Erdmann; O Fisher; C Fondevila; Å Fretland; F Garcia Borobia; A Gelabert; L Gérard; F Giuliante; P D Gobardhan; F Gómez; T Grünberger; D J Grünhagen; J Guitart; J Hagendoorn; J Heil; D Heise; E Herrero; G F Hess; M H Hoffmann; R Iezzi; F Imani; J Nguyen; E Jovine; J C Kalff; G Kazemier; T P Kingham; J Kleeff; O Kollmar; W K G Leclercq; S Lopez Ben; V Lucidi; A MacDonald; D C Madoff; S Manekeller; G Martel; A Mehrabi; H Mehrzad; M R Meijerink; K Menon; P Metrakos; C Meyer; A Moelker; S Modi; N Montanari; J Navines; U P Neumann; P Peddu; J N Primrose; X Qu; D Raptis; F Ratti; F Ridouani; C Rogan; U Ronellenfitsch; S Ryan; C Sallemi; J Sampere Moragues; P Sandström; L Sarriá; A Schnitzbauer; M Serenari; A Serrablo; M L J Smits; E Sparrelid; E Spüntrup; G A Stavrou; R P Sutcliffe; I Tancredi; J C Tasse; V Udupa; D Valenti; Y Fundora; T J Vogl; X Wang; S A White; W A Wohlgemuth; D Yu; I A J Zijlstra; C A Binkert; M H A Bemelmans; C van der Leij
Journal:  Cardiovasc Intervent Radiol       Date:  2022-07-05       Impact factor: 2.797

8.  Liver venous deprivation for resection of advanced hilar cholangiocarcinoma-a case report and review of the literature.

Authors:  Radoslava Stoyanova; Helmut Kopf; Wolfgang Schima; Wolfgang Karl Matzek; Alexander Klaus
Journal:  Explor Target Antitumor Ther       Date:  2022-02-28

Review 9.  Induction of liver hypertrophy for extended liver surgery and partial liver transplantation: State of the art of parenchyma augmentation-assisted liver surgery.

Authors:  Philip C Müller; Michael Linecker; Elvan O Kirimker; Christian E Oberkofler; Pierre-Alain Clavien; Deniz Balci; Henrik Petrowsky
Journal:  Langenbecks Arch Surg       Date:  2021-03-19       Impact factor: 3.445

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.